Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2011-07-18

FDA Approved: DIETHYLPROPION HYDROCHLORIDE — Original Application (Chartwell RX, LLC.)

View source ↗

Summary

The FDA approved Chartwell RX, LLC's generic diethylpropion hydrochloride under ANDA 200177 for short-term weight management in obesity.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Diethylpropion hydrochloride (Diethylpropion hydrochloride)

Snippet

ORIG AP for DIETHYLPROPION HYDROCHLORIDE (DIETHYLPROPION HYDROCHLORIDE)